| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |